Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1387508 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,284,609
+$137,998 QoQ
Shares Held
50,635
-0.2% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#83
of 251 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names. PCRX ranks #5 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 PCRX
Pacira BioSciences, Inc.
This page
50,635 $1,284,609

All Filings in PCRX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,284,609 50,635
2026-03-31 $1,146,611 50,735
2025-12-31 $1,138,590 43,995
2025-09-30 $941,506 36,535
2025-06-30 $579,216 24,235
2025-03-31 $604,824 24,339
2024-12-31 $368,039 19,535
2024-09-30 $330,121 21,935
2024-06-30 $555,520 19,417
2024-03-31 $424,420 14,525
2023-12-31 $225,518 6,684
2023-06-30 $280,089 6,990
2022-06-30 $573,497 9,837
2022-03-31 $560,646 7,346
2021-12-31 $711,630 11,827
2020-06-30 $810,504 15,447
2020-03-31 $415,403 12,389